Of note, similar results were obtained after CLDN1 knockdown, thereby revealing CLDN1’s ability to maintain effective FGFR-signaling in IM-resistant GIST and thereby promoting FGFR-mediated survival in KIT-inhibited GIST. The gene discussed is CLDN1; the disease is gastrointestinal stromal tumor.